What are the in silico studies show antibacterial activity on alpha carbonic anhydrase?5 answersIn silico studies have shown that compounds C11 and C37 exhibit significant affinity scores against alpha carbonic anhydrase. Additionally, cyclic urea 9c has been found to inhibit VchαCA, a type of alpha carbonic anhydrase, with nanomolar affinity. Furthermore, griseofulvin and usnic acid sulfonamides have also shown interesting inhibition activity against alpha carbonic anhydrase. These findings suggest that these compounds have potential antibacterial activity against alpha carbonic anhydrase.
How might changing the pH affect an enzyme's activity?5 answersChanging the pH can significantly affect an enzyme's activity. The pH of the solution can influence the binding of ligands to the active site of the enzyme, especially in enzymes that are sensitive to pH. The protonation and deprotonation of acidic residues in the active site in response to pH changes strongly influence ligand binding. Additionally, the optimal pH (pHopt) at which enzymes function is crucial for their catalytic activity. Computational methods, such as EpHod, have been developed to predict pHopt directly from the protein sequence, which can aid in enzyme discovery and design. Furthermore, a pH-responsive nucleic acid structure has been developed, which can control the activity of an enzyme protein by adjusting the pH to regulate the accessibility of the enzyme protein to its substrate.
Does carbonic anhydrase play a role in Parkinson?5 answersCarbonic anhydrase does not play a role in Parkinson's disease.
Association between CArbonic anhydrase II INHIBITORwith WNT Signaling pathway?5 answersThe association between carbonic anhydrase II (CAII) inhibitor and the WNT signaling pathway is not directly addressed in the provided abstracts. However, the abstracts do mention the involvement of other carbonic anhydrases (CA4 and CAIII) in the WNT signaling pathway. CA4 is identified as a novel tumor suppressor in colorectal cancer (CRC) through the inhibition of the WNT signaling pathway by targeting the WTAP-WT1-TBL1 axis. CAIII is highly expressed in osteocytes and is regulated by parathyroid hormone, protecting osteocytes from oxidative stress. While the abstracts provide insights into the role of carbonic anhydrases in cancer and bone biology, they do not specifically address the association between CAII inhibitor and the WNT signaling pathway. Further research may be needed to explore this specific association.
Do carbonic anhydrase inhibitors change thyroid hormone levels?4 answersCarbonic anhydrase inhibitors can affect thyroid hormone levels. In patients with hyperthyroid Graves' disease, both red blood cell (RBC) carbonic anhydrase I isozyme (CA1) and zinc (Zn) concentrations were found to be decreased. After treatment, the normalization of RBC CA1 and Zn levels lagged behind the normalization of plasma thyroxine (T4) and triiodothyronine (T3) levels. In contrast, transient thyrotoxicosis due to destructive thyroiditis did not cause significant changes in RBC CA1 and Zn concentrations. Additionally, carbamazepine (CBZ), a carbonic anhydrase inhibitor, was found to decrease total thyroxine (TT4) and free thyroxine (FT4) serum levels in thyroxine-supplemented hypothyroid patients, potentially leading to subclinical or overt hypothyroidism. These findings suggest that carbonic anhydrase inhibitors can have an impact on thyroid hormone levels and should be monitored in patients with thyroid disorders.
Do carbonic anhydrase inhibitors effect thyroid ?5 answersCarbonic anhydrase inhibitors have been found to have an effect on the thyroid. In patients with thyrotoxicosis, the concentration of erythrocyte carbonic anhydrase-I (C.A.I.) was found to be below the normal range. Additionally, in patients taking oral contraceptives, a low erythrocyte-C.A.I. concentration was noted, particularly among those taking low-estrogen contraceptives. These findings suggest that erythrocyte-C.A.I. estimation could serve as a rapid screening test for thyrotoxicosis.